Medical Policy: 09.03.01 

Original Effective Date: November 1997 

Reviewed: January 2021 

Revised: January 2018 



This policy contains information which is clinical in nature. The policy is not medical advice. The information in this policy is used by Wellmark to make determinations whether medical treatment is covered under the terms of a Wellmark member's health benefit plan. Physicians and other health care providers are responsible for medical advice and treatment. If you have specific health care needs, you should consult an appropriate health care professional. If you would like to request an accessible version of this document, please contact customer service at 800-524-9242.


Benefit Application:

Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions may apply. Benefits may vary based on contract, and individual member benefits must be verified. Wellmark determines medical necessity only if the benefit exists and no contract exclusions are applicable. This medical policy may not apply to FEP. Benefits are determined by the Federal Employee Program.


This Medical Policy document describes the status of medical technology at the time the document was developed. Since that time, new technology may have emerged or new medical literature may have been published. This Medical Policy will be reviewed regularly and be updated as scientific and medical literature becomes available.



Corneal Topography

Corneal topography describes measurements of the curvature of the cornea. An evaluation of corneal topography is necessary for the accurate diagnosis and follow-up of certain corneal disorders, such as keratoconus, difficult contact lens fits, and pre- and postoperative assessment of the cornea, most commonly after refractive surgery. Various techniques and instruments are available to measure corneal topography:

  • The keratometer (also referred to as an ophthalmometer), the most commonly used instrument, projects an illuminated image onto a central area in the cornea. By measuring the distance between a pair of reflected points in both of the cornea’s 2 principal meridians, the keratometer can estimate the radius of curvature of 2 meridians. The fact that the keratometer can only estimate the corneal curvature over a small percentage of its surface, and that estimates are based on the frequently incorrect assumption that the cornea is spherical, are limitations of this technique.
  • The keratoscope is an instrument that reflects a series of concentric circular rings off the anterior corneal surface. Visual inspection of the shape and spacing of the concentric rings provides a qualitative assessment of topography. A photokeratoscope is a keratoscope equipped with a camera that can provide a permanent record of the corneal topography.
  • Computerized or Computer-assisted photokeratoscopy (also known as Computer Assisted Video Keratography [CAVK] and corneal mapping) is an alternative to keratometry or keratoscopy in measuring corneal curvature. This technique uses sophisticated image analysis programs to provide quantitative corneal topographic data. Early computer-based programs were combined with keratoscopy to create graphic displays and high-resolution color-coded maps of the corneal surface. Newer technologies measure both curvature and shape, enabling quantitative assessment of corneal depth, elevation, and power.


Optical Coherance Tomography

Optical coherence tomography (OCT) devices employ non-invasive, non-contact, low-coherence interferometry to obtain high-resolution images and measurements of the anterior segment ocular structures (cornea, anterior chamber, iris and the central portion of the lens).


The devices are designed to image the shape, size and position of anterior components and make precise measurements of the distances between them, including angle-to-angle, angle size in degrees, pupil diameter, anterior chamber depth, and thickness and radii of curvature of the crystalline lens. The anterior segment is measured pre- and postoperatively for laser surgery in refractive surgeries.


Gonioscopy is the gold standard for evaluation of the anterior segment of the eye.


Optical coherence tomography (OCT) has also been used to measure the anterior segment of the eye. Several studies have compared OCT and established techniques to measure the anterior segment ocular structure, but none have established the superiority of OCT.


There is some evidence that the high-resolution images provided by anterior segment optical coherence tomography (AS OCT) are superior to results from slit-lamp examination or gonioscopy for some indications. However, current literature is very limited.


Practice Guidelines and Position Statements

The American Academy of Ophthalmology (AAO)

Assessment indicates that computer-assisted corneal topography evolved from the need to measure corneal curvature and topography more comprehensively and accurately than keratometry and that corneal topography is used primarily for refractive surgery. AAO indicates several other potential uses: (1) evaluate and manage patients following penetrating keratoplasty, (2) plan astigmatic surgery, (3) evaluate patients with unexplained visual loss and document visual complications, and (4) fit contact lenses. However, the AAO assessment noted that data are lacking to support the use of objective measurements, as opposed to subjective determinants (subjective refraction) of astigmatism.


The American Academy of Ophthalmology Preferred Practice Pattern® Summary Benchmarks for primary angle closure, primary open-angle, and primary open-angle suspect recommend gonioscopy as a key element in the workup and management of primary angle and suspect. Optical coherence tomography (OCT) is not mentioned.


Regulatory Status

A number of devices have received clearance for marketing through the U.S. Food and Drug Administration (FDA) 510(k) mechanism. The Orbscan (manufactured by Orbtek and distributed by Bausch and Lomb) received FDA clearance in 1999. The second generation Orbscan II is a hybrid system that uses both projective (slit scanning) and reflective (Placido) methods. The Pentacam (Oculus) is one of a number of rotating imaging system. Newer approved systems include Galilei G6 Professional and the VX130 Ophthalmic Diagnostic Device.  


Prior Approval:

Not applicable



Corneal Topography

An evaluation of corneal topography may be considered medically necessary for the following conditions:

  • Corneal dystrophy bullous keratopathy and complications of transplanted cornea (once per lifetime)
  • Post-traumatic corneal scarring (once per lifetime)
  • Diagnosing and monitoring disease progression in Keratoconus (once per lifetime)


Computerized corneal topography (92025) is a diagnostic test and routine serial testing is considered not medically necessary.


All other uses of corneal topography are considered not medically necessary, including but not limited to:

  • When used in conjunction with preoperative evaluation for cataract surgery including refractive intraocular lens (IOL) exchange and premium channel IOL cataract surgery.
  • For difficult fitting of contact lens
  • Refractive surgery


Note: Non-computerized topography is considered integral to the evaluation and management services. This is included in the payment for these services.


Optical Coherence Tomography

Optical coherence tomography of the anterior eye segment (AS OCT) (92132) is considered not medically necessary for all indications. Its clinical value has yet to be established.


Procedure Codes and Billing Guidelines:

To report provider services, use appropriate CPT* codes, Modifiers, Alpha Numeric (HCPCS level 2) codes, Revenue codes, and/or diagnosis codes.

  • 92025 Computerized corneal topography, unilateral or bilateral, with interpretation and report
  • 92132 Scanning computerized ophthalmic diagnostic imaging, anterior segment, with interpretation and report, unilateral or bilateral
  • 0604T Optical coherence tomography (OCT) of retina, remote, patient initiated image capture and transmission to a remote surveillance center unilateral or bilateral; initial device provision, set-up and patient education on use of equipment
  • 0605T Optical coherence tomography (OCT) of retina, remote, patient initiated image capture and transmission to a remote surveillance center unilateral or bilateral; remote surveillance center technical support, data analyses and reports, with a minimum of 8 daily recordings, each 30 days
  • 0606T   Optical coherence tomography (OCT) of retina, remote, patient initiated image capture and transmission to a remote surveillance center unilateral or bilateral; review, interpretation and report by the prescribing physician or other qualified health care professional of remote surveillance center data analyses, each 30 days 


Selected References:

  • American Academy of Ophthalmology. Ophthalmic procedure preliminary assessment; Corneal Topography. Ophthalmology1999;106:1628-1638.
  • Rao SK, Padmanabhan P. Understanding Corneal Topography. Ophthalmology 2000;11:248-259.
  • Klyce SD. Corneal topography and the new wave. Cornea 2000;19(5):723-73-29.
  • Center for Medicare and medicaid Services (CMS) Wisconsin Physicians Service Insurance Corporation. LCD for Corneal Topography (L29971)  Retired
  • Reddy SP, Bansal R. Corneal topography and corneal thickness in children. Journal of Pediatric Ophthalmology and Strabismus 2013, 50(5):304-310
  • Lee H, Chung JL, Kim EK et al. Univariate and bivariate polar value analysis of corneal astigmatism measurements obtained with 6 instruments. J Cataract Refract Surg 2012; 38(9):1608-15.
  • Neri A, Ruggeri M, Protti A, et al. Dynamic imaging of accommodation by swept-source anterior segment optical coherence tomography. J Cataract Refract Surg. 2015; 41(3):501-510
  • Zhao PS, Wong TY, Wong WL, et al. Comparison of central corneal thickness measurements by visante anterior segment optical coherence tomography with ultrasound pachymetry. Am J Ophthalmol. 2007; 143(6):1047-1049.
  • Mansouri K, Sommerhalder J, Shaarawy T. Prospective comparison of ultrasound biomicroscopy and anterior segment optical coherence tomography for evaluation of anterior chamber dimensions in European eyes with primary angle closure. Eye (Lond). 2010; 24(2):233-239.
  • American Academy of Ophthalmology (AAO) Preferred practice pattern benchmarks (2014).
  • Kojima S, Inoue T, Nakashima K, et al. Filtering blebs using 3-dimensional anterior-segment optical coherence tomography: A prospective investigation. JAMA Ophthalmol. 2015;133(2):148-156.
  • Weber SL, Ambrosio R, Jr., Lipener C, et al.(2016) The use of ocular anatomical measurements using a rotating Scheimpflug camera to assist in the Esclera(R) scleral contact lens fitting process. Cont Lens Anterior Eye. Apr 2016;39(2):148-153. PMID 26474924
  • Venkateswaran, N., Galor, A., Wang, J. et al. Optical coherence tomography for ocular surface and corneal diseases: a review. Eye and Vis 5, 13 (2018) doi:10.1186/s40662-018-0107-0
  • Tran, A.Q., Venkateswaran, N., Galor, A. et al. Utility of high-resolution anterior segment optical coherence tomography in the diagnosis and management of sub-clinical ocular surface squamous neoplasia. Eye and Vis 6, 27 (2019) doi:10.1186/s40662-019-0152-3
  • Venkat A, Englander M, Xu D, Kaiser P. Optical coherence tomography in retinal imaging. In: Yanoff M and Duker J. Ophthalmology, 5th Ed. Philadelphia, PA: Saunders; 2019:450-456.e1.


Policy History:

  • January 2021 - Annual Review, Policy Renewed
  • January 2020 - Annual Review, Policy Renewed
  • January 2019 - Annual Review, Policy Renewed
  • January 2018 - Annual Review, Policy Revised
  • January 2017 - Annual Review, Policy Renewed
  • January 2016 - Annual Review, Policy Revised
  • January 2015 - Annual Review, Policy Revised
  • February 2014 - Annual Review, Policy Renewed
  • March 2013 - Annual Review, Policy Renewed
  • March 2012 - Annual Review, Policy Renewed
  • April 2011 - Annual Review, Policy Renewed

Wellmark medical policies address the complex issue of technology assessment of new and emerging treatments, devices, drugs, etc.   They are developed to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. Wellmark medical policies contain only a partial, general description of plan or program benefits and do not constitute a contract. Wellmark does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Wellmark or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. Our medical policies may be updated and therefore are subject to change without notice.


*CPT® is a registered trademark of the American Medical Association.